about
Multicenter Evaluation of the New Abbott RealTime Assays for Quantitative Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNAAntiviral treatment for human immunodeficiency virus patients co-infected with hepatitis B virus: combined effect for both infections, an obtainable goal?Molecular detection and typing of influenza viruses: are we ready for an influenza pandemic?Preparing the outbreak assistance laboratory network in the Netherlands for the detection of the influenza virus A(H1N1) variant.Evaluation of the antiviral response to zanamivir administered intravenously for treatment of critically ill patients with pandemic influenza A (H1N1) infection.Influenza in the immediate post-pandemic era: a comparison with seasonal and pandemic influenza in hospitalized patients.Sequence evidence for RNA recombination in field isolates of avian coronavirus infectious bronchitis virus.Morbilliviruses in Mediterranean monk seals.Molecular epidemiology of gibbon hepatitis B virus transmission.Nucleoside analogues for chronic hepatitis B.Quantitation of viral load using real-time amplification techniques.Detection of hepatitis B virus genotypes and mutants: current status.Evaluation of a multiplex reverse transcriptase PCR ELISA for the detection of nine respiratory tract pathogens.Infection prevention in a connected world: the case for a regional approach.Pediatric parechovirus infections.Diagnosing herpesvirus infections by real-time amplification and rapid culture.Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients.The effect of pegylated interferon-alpha on the treatment of lamivudine resistant chronic HBeAg positive hepatitis B virus infection.The emergence of enterovirus D68 in a Dutch University Medical Center and the necessity for routinely screening for respiratory viruses.Phylogeny of antigenic variants of avian coronavirus IBV.Validation of the INNO-LiPA HBV DR assay (version 2) in monitoring hepatitis B virus-infected patients receiving nucleoside analog treatment.Seasonal influenza vaccine effectiveness against influenza in 2012-2013: a hospital-based case-control study in Lithuania.The clinical course of hepatitis E virus infection in patients of a tertiary Dutch hospital over a 5-year period.Human herpesvirus-6 DNAemia is a sign of impending primary CMV infection in CMV sero-discordant renal transplantations.The development of a qualitative real-time RT-PCR assay for the detection of hepatitis C virus.Evaluation of the analytical performance of the new Abbott RealTime RT-PCRs for the quantitative detection of HCV and HIV-1 RNA.Avian flu: multiple introductions of H5N1 in Nigeria.Circulation of incorrectly labeled adenovirus 50 and 51 prototype preparations.Morbillivirus in monk seal mass mortality.The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus.Conversion from cyclosporin A to tacrolimus is safe and decreases blood pressure, cholesterol levels and TGF-beta 1 type I receptor expression.Persistence of YMDD variants after withdrawal of Lamivudine.The significance of rhinovirus detection in hospitalized children: clinical, epidemiological and virological features.Viral dynamics during and after entecavir therapy in patients with chronic hepatitis B.Infectious RNA transcripts from Ross River virus cDNA clones and the construction and characterization of defined chimeras with Sindbis virus.Viral dynamics in chronic hepatitis B patients treated with lamivudine, lamivudine-famciclovir or lamivudine-ganciclovir.Granzyme expression in fine-needle aspirates from liver allografts is increased during acute rejection.Chronic hepatitis E infection in lung transplant recipients.Sequence-based identification and characterization of nosocomial influenza A(H1N1)pdm09 virus infections.
P50
Q27480924-F20604D6-2873-4623-8980-4457B5E1FFD8Q28376360-664AB410-9905-4EA2-9A92-A2A62AF49052Q30368388-95E95D31-235B-4EF6-A929-C877C0412539Q30378238-B71BD8BC-3335-4384-A5FA-F47C86D923F0Q30406007-156A8C2A-E9A9-45B2-ABC6-A5B7D53436E1Q30414000-38B009FB-CC9C-4239-9826-9ED61EF18D83Q33262556-E9097C48-2C16-438E-B3B3-80961A95E962Q33748829-817B1D27-9F0E-4A07-BF16-32B148704321Q34171316-019D03B8-8405-4CAF-909A-101B5884C91BQ34462270-E2B35A02-D513-4BCF-ADD8-D3FFF7ABAA13Q34532452-31B06FE1-B1D4-424A-9574-B7221E5DC51EQ36388368-4F930CB1-C506-43BB-936C-9A2944C958A5Q37867192-762137AC-39C7-4A10-8F50-96EDF7DFAB69Q38090176-F932A43A-6F4F-454B-B34C-40956177F7A8Q38201180-3CF8CBA8-14D2-4ABA-8BBF-451BD7987AA4Q39733154-8C311808-E349-482D-AF8A-BCA46A477248Q40279797-03F37EBC-B57C-4D42-B2AF-F5D32995C60BQ40353111-ABFA96D5-EE1A-47C5-95E1-F0BDFEEC6D18Q41580365-2C3BF8F1-6F2A-4EB0-92A8-FAFC36970B3BQ41865889-EA6039A6-92A2-440B-AD64-A63E5DC1E0EAQ42124703-952F28EE-2FAE-45F3-A995-45897189A953Q42235495-3F7F4CB1-7184-4FEA-805A-6A392A94AFDCQ42268042-3970EF21-01E3-49E5-82E1-33E8C3E1BB76Q42277189-767631F3-31AC-4A59-B2B7-EF60312DDEFDQ42979083-0A9D9863-0C51-4D05-A66F-BE1BBD5D0925Q43040408-64511273-9DF2-4DDE-BE7F-817B0D0586EFQ43176762-AEFE94D7-771D-45CF-8BB9-860FD9500DA7Q43247193-C0B988C3-3E1C-4E3E-8228-44CBF0C4EC3FQ43522157-4EC4A5C1-0294-41ED-970F-B691A5852BA9Q43684271-479D881E-2E4B-42FD-B3E2-05077052CED5Q43684819-FC167D3B-E7E5-46D9-AD45-34B28DE285A6Q43782409-8DDAE45B-C223-486A-98E0-5F3FBC075730Q43878375-E72351F1-5F99-4631-BEFA-B719D2770701Q43908840-E1114AA3-8A0A-4C4A-9E5A-7E4EA2EAF1C9Q44036843-D0F41285-7EC6-40B3-B9D0-71FCD8A6923FQ44143039-2C056D91-39FA-4883-89C1-05D2147D8337Q44156676-0B0B327F-3374-48D1-A08D-92130895D836Q44165120-422AA547-FE0D-499D-A734-64DB7CA104A4Q44180185-1F19B162-C7D3-45C8-AB4D-FA79DA42FC81Q44183103-0BD66055-5228-4BAC-8C03-8F31331204F0
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Hubert G. Niesters
@ast
Hubert G. Niesters
@en
Hubert G. Niesters
@es
Hubert G. Niesters
@nl
Hubert G. Niesters
@sl
type
label
Hubert G. Niesters
@ast
Hubert G. Niesters
@en
Hubert G. Niesters
@es
Hubert G. Niesters
@nl
Hubert G. Niesters
@sl
altLabel
Bert Niesters
@en
prefLabel
Hubert G. Niesters
@ast
Hubert G. Niesters
@en
Hubert G. Niesters
@es
Hubert G. Niesters
@nl
Hubert G. Niesters
@sl
P106
P1153
7006807127
P21
P31
P496
0000-0002-1758-0430